期刊文献+

心电图ST段抬高、压低幅度及持续时间与冠心病患者冠脉病变程度的相关性分析 被引量:3

下载PDF
导出
摘要 目的分析心电图ST段抬高、压低幅度及持续时间与冠心病患者冠脉病变程度的相关性。方法选择2019年2月-2020年10月期间于宜春市中医院进行治疗的62例冠心病患者,根据冠脉病变程度分为3组,分别为单支组(n=21)、双支组(n=21)以及多支组(n=20)。比较3组患者心电图上ST段抬高、ST段压低检出率,ST段改变情况、持续时间,分析ST段改变情况与冠脉病变程度的相关性。结果除多支组ST段抬高检出率显著高于单支组外,各组ST段抬高、ST段压低检出率差异并无统计学意义(P>0.05);单支组患者和双支组患者ST段抬高幅度、ST段抬高持续时间以及ST段压低幅度、ST段压低持续时间均明显较多支组低,且单支组均较双支组低,差异有统计学意义(P<0.05);Spearman分析显示,ST段抬高幅度及ST段抬高持续时间与患者冠脉病变程度呈中度相关,ST段压低幅度及ST段压低持续时间与患者冠脉病变程度呈低度相关(P<0.05)。结论心电图ST段抬高、压低幅度及持续时间与冠心病患者冠脉病变程度密切相关,建议临床关注上述心电图特征以调整诊疗策略。
作者 黄曦 何恢健
机构地区 宜春市中医院
出处 《基层医学论坛》 2023年第7期88-90,共3页 The Medical Forum
  • 相关文献

参考文献4

二级参考文献44

  • 1黄恒贵.心电图QRS波时限与血清ApoB/ApoA-Ⅰ比值在冠心病患者冠脉病变严重程度评估中的价值[J].武汉大学学报(医学版),2020,41(1):114-118. 被引量:9
  • 2Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery ( EACTS ), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, et al. Guidelines on myocardial revascularization. Eur Heart J,2010 , 31:2501-2555.
  • 3Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation, 2011, 124 :e574-651.
  • 4Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coil Cardiol, 2011,58 :e123-210.
  • 5Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation ( EuroSCORE ). Eur J Cardiothorac Surg, 1999,16:9-13.
  • 6Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009,360:961- 972.
  • 7Peterson ED, Dai D, DeLong ER, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coil Cardiol,2010,55:1923-1932.
  • 8Online STS fish calculator [ S/OL]. [ 2012-01-01 ]. http:// riskcalc, sts. org/STSWebRiskCalc273/de, aspx.
  • 9Mehta SR, Tanguay JF, Eikelboom JW, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes ( CURRENT-OASIS 7 ): a randomised factorial trial. Lancet,2010,376 : 1233-1243.
  • 10Mehta SR, Granger CB, Eikelboom JW, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Cell Cardiol,2007,50 : 1742-1751.

共引文献442

同被引文献39

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部